Oncology Institute (TOI) Short Interest Ratio & Short Volume $0.20 -0.01 (-2.86%) (As of 05:45 PM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Oncology Institute Short Interest DataOncology Institute (TOI) has a short interest of 1.24 million shares, representing 3.37% of the float (the number of shares available for trading by the public). This marks a 193.91% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.8, indicating that it would take 0.8 days of the average trading volume of 538,231 shares to cover all short positions.Current Short Interest1,240,000 sharesPrevious Short Interest421,900 sharesChange Vs. Previous Month+193.91%Dollar Volume Sold Short$200,880.00Short Interest Ratio0.8 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares75,559,000 sharesFloat Size36,770,000 sharesShort Percent of Float3.37%Today's Trading Volume597,457 sharesAverage Trading Volume538,231 sharesToday's Volume Vs. Average111% Short Selling Oncology Institute? Sign up to receive the latest short interest report for Oncology Institute and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTOI Short Interest Over TimeTOI Days to Cover Over TimeTOI Percentage of Float Shorted Over Time Ad DTIA brand new opportunity in the stock market revealedToday, I want to unlock a brand new opportunity in the stock market… One that has been able to pay out around 100% in 5 days or less so far on REAL money… It’s all thanks to a hidden force that drives some of the BIGGEST & most repetitive moves in stocks… I call it a Gamma Pocket…Will you be the next trader to discover the power of Gamma Pockets? Oncology Institute Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20241,240,000 shares $200,880.00 +193.9%3.4%0.8 $0.16 11/15/2024421,900 shares $75,942.00 +70.1%1.1%0.4 $0.18 10/31/2024248,000 shares $76,880.00 -1.5%0.7%1.7 $0.31 10/15/2024251,800 shares $80,802.62 -0.3%0.8%2 $0.32 9/30/2024252,500 shares $82,542.25 +8.4%0.8%2 $0.33 9/15/2024233,000 shares $76,703.60 -22.8%0.7%1.8 $0.33 Get the Latest News and Ratings for TOI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024301,700 shares $108,853.36 +25.2%0.9%2.1 $0.36 8/15/2024240,900 shares $86,242.20 +9.6%0.7%1.4 $0.36 7/31/2024219,900 shares $120,065.40 -15.8%0.7%1.3 $0.55 7/15/2024261,000 shares $130,500.00 -13.5%0.8%1.5 $0.50 6/30/2024301,800 shares $138,828.00 +29.8%1.0%1.8 $0.46 6/15/2024232,600 shares $104,670.00 +13.2%0.7%1.3 $0.45 5/31/2024205,500 shares $101,558.10 -5.6%0.7%1.1 $0.49 5/15/2024217,600 shares $148,838.40 -18.9%0.7%1.3 $0.68 4/30/2024268,400 shares $284,504.00 +6.5%0.9%2.2 $1.06 4/15/2024252,000 shares $299,880.00 -4.1%0.8%2.2 $1.19 3/31/2024262,700 shares $415,066.00 +12.1%0.8%2.1 $1.58 3/15/2024234,300 shares $393,624.00 +3.8%0.8%1.7 $1.68 2/29/2024225,700 shares $424,316.00 -7.0%0.7%1.2 $1.88 2/15/2024242,600 shares $434,254.00 -20.8%0.8%1.1 $1.79 1/31/2024306,200 shares $627,710.00 -7.5%1.0%1.1 $2.05 1/15/2024330,900 shares $684,963.00 +20.3%0.8%1.1 $2.07 12/31/2023275,000 shares $561,000.00 +51.3%0.7%0.9 $2.04 12/15/2023181,800 shares $245,430.00 -35.0%0.7%0.6 $1.35 11/30/2023279,800 shares $478,458.00 -37.4%1.1%1 $1.71 11/15/2023447,000 shares $992,340.00 +91.3%1.7%1.8 $2.22 10/31/2023233,700 shares $446,367.00 -4.6%0.9%1 $1.91 10/15/2023245,000 shares $379,750.00 -8.8%0.9%1.2 $1.55 9/30/2023268,500 shares $375,900.00 +6.2%1.0%1 $1.40 9/15/2023252,900 shares $417,285.00 -11.9%1.0%0.9 $1.65 8/31/2023286,900 shares $332,804.00 -17.9%0.9%0.4 $1.16 8/15/2023349,300 shares $299,629.54 +42.0%1.1%0.4 $0.86 7/31/2023246,000 shares $240,440.40 -45.3%0.8%0.3 $0.98 7/15/2023450,000 shares $319,635.00 -7.3%1.4%0.5 $0.71 6/30/2023485,400 shares $267,067.08 -74.3%1.5%0.6 $0.55 6/15/20231,890,000 shares $1.14 million +39.0%6.0%2.4 $0.61 5/31/20231,360,000 shares $581,400.00 +5.4%4.4%2.1 $0.43 5/15/20231,290,000 shares $580,500.00 +1.6%4.1%6.6 $0.45 4/30/20231,270,000 shares $647,700.00 +5.8%4.1%7.4 $0.51 4/15/20231,200,000 shares $716,760.00 +2.6%3.9%6.9 $0.60Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover 3/31/20231,170,000 shares $793,143.00 +13.6%3.8%7.2 $0.68 3/15/20231,030,000 shares $682,066.00 +12.0%3.5%5.7 $0.66 2/28/2023919,300 shares $1.30 million -21.4%3.2%6.7 $1.41 2/15/20231,170,000 shares $1.83 million -14.6%4.0%6.9 $1.56 1/31/20231,370,000 shares $2.03 million +31.7%4.7%7.1 $1.48 1/15/20231,040,000 shares $1.77 million +4.0%3.6%5.2 $1.70 12/30/20221,000,000 shares $1.65 million -8.3%3.8%5.1 $1.65 12/15/20221,090,000 shares $1.00 million +39.6%4.2%5.6 $0.92 11/30/2022780,600 shares $1.10 million -17.0%3.0%3.9 $1.41 11/15/2022940,500 shares $1.92 million -3.4%3.6%5.6 $2.04 10/31/2022973,100 shares $4.42 million -8.2%3.7%7 $4.54 10/15/20221,060,000 shares $4.71 million -18.5%4.1%8.4 $4.44 9/30/20221,300,000 shares $6.02 million +46.7%5.1%10.8 $4.63 9/15/2022886,100 shares $4.08 million -6.6%3.5%6 $4.61 8/31/2022948,900 shares $6.03 million +0.0%3.7%7.8 $6.35 8/15/2022948,700 shares $5.87 million +8.1%3.8%7.5 $6.19 7/31/2022878,000 shares $5.67 million -4.3%3.5%6.8 $6.46 7/15/2022917,000 shares $5.36 million +15.0%3.6%6.7 $5.84 6/30/2022797,600 shares $4.04 million +83.2%3.1%5.7 $5.06 6/15/2022435,400 shares $2.79 million -24.7%1.7%3.1 $6.40 5/31/2022578,100 shares $5.21 million +5.2%2.3%5.6 $9.01 5/15/2022549,300 shares $3.36 million -8.6%2.2%4.7 $6.12 4/30/2022600,800 shares $4.72 million +5.0%2.5%5.8 $7.86 4/15/2022572,000 shares $3.95 million +3.2%2.4%6.1 $6.90 3/31/2022554,100 shares $3.95 million +9.0%2.2%5.8 $7.13 3/15/2022508,500 shares $3.48 million -21.6%2.0%4.3 $6.84 2/28/2022648,800 shares $3.48 million +4.9%2.5%5.2 $5.37 2/15/2022618,500 shares $3.90 million 0.0%2.4%4.8 $6.31 1/31/2022618,700 shares $4.00 million +2.3%2.4%4.5 $6.46 1/15/2022605,100 shares $4.74 million +8.7%2.3%3.8 $7.83 12/31/2021556,500 shares $5.43 million No Change2.2%3.6 $9.75 TOI Short Interest - Frequently Asked Questions What is Oncology Institute's current short interest? Short interest is the volume of Oncology Institute shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 1,240,000 shares of TOI short. 3.37% of Oncology Institute's shares are currently sold short. Learn More on Oncology Institute's current short interest. What is a good short interest ratio for Oncology Institute? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TOI shares currently have a short interest ratio of 1.0. Learn More on Oncology Institute's short interest ratio. What is a good short interest percentage for Oncology Institute? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.37% of Oncology Institute's floating shares are currently sold short. Is Oncology Institute's short interest increasing or decreasing? Oncology Institute saw a increase in short interest in November. As of November 30th, there was short interest totaling 1,240,000 shares, an increase of 193.9% from the previous total of 421,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Oncology Institute's float size? Oncology Institute currently has issued a total of 75,559,000 shares. Some of Oncology Institute's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Oncology Institute currently has a public float of 36,770,000 shares. How does Oncology Institute's short interest compare to its competitors? 3.37% of Oncology Institute's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Oncology Institute: Enzo Biochem, Inc. (1.16%), Concord Medical Services Holdings Limited (0.16%), Psychemedics Co. (1.25%), BioRestorative Therapies, Inc. (1.32%), OpGen, Inc. (0.19%), Kindly MD, Inc. (10.74%), Ontrak, Inc. (1.26%), Mangoceuticals, Inc. (9.13%), Vsee Health, Inc. (5.75%), Agape ATP Co. (5.12%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short Oncology Institute stock? Short selling TOI is an investing strategy that aims to generate trading profit from Oncology Institute as its price is falling. TOI shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Oncology Institute? A short squeeze for Oncology Institute occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TOI, which in turn drives the price of the stock up even further. How often is Oncology Institute's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TOI, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies Enzo Biochem Short Interest Concord Medical Services Short Interest Psychemedics Short Interest BioRestorative Therapies Short Interest OpGen Short Interest Kindly MD Short Interest Ontrak Short Interest Mangoceuticals Short Interest Vsee Health Short Interest Agape ATP Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TOI) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.